Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanfacine for Spatial Neglect and Impaired Vigilance after Stroke or Focal Brain Damage
2008-001160-36Phase 2Completed
- Sponsor
- Imperial College London
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of guanfacine in hemispatial neglect, Impaired vigilance, stroke and 1 more, sponsored by Imperial College London. Primary endpoint: Completion of 5-day trial period. Started Apr 2009; status: completed.
02
Drugs
guanfacine
03
Conditions
hemispatial neglectImpaired vigilancestroketraumatic brain injury (TBI)
Beyond the preview
Go deeper on 2008-001160-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001160-36.